These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt||2014-005101-21||Safety, tolerability, systemic pharmacokinetics and efficacy of a single dose of Osteogrow (rhBMP6 in autologous Whole Blood Coagulum Derived [WBCD] carrier) delivered locally to the fracture site in ...||not-yet-due|
|Exempt||2015-001691-21||SAFETY, TOLERABILITY, rhBMP6 PHARMACOKINETICS AND BONE HEALING EFFECT OF A SINGLE DOSE OF OSTEOGROW (rhBMP6 IN AUTOLOGOUS WHOLE BLOOD COAGULUM DERIVED [WBCD] CARRIER) IN ADULT PATIENTS TREATED BY HIGH...||2021-09-07||not-yet-due|
|Ongoing||2017-000860-14||Patient and evaluator blinded non-inferiority study on safety, tolerability and lumbar fusion efficacy of a single administration of Osteogrow (rhBMP6 in autologous blood coagulum (ABC) carrier) in ad...||not-yet-due|
|Ongoing||2021-004034-11||A randomized, evaluator-blinded, dose-ranging, proof of concept study of efficacy, safety and tolerability of rhBMP6 (delivered in autologous blood coagulum [ABC] supplemented with synthetic ceramics ...||not-yet-due|